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Bifurcation type
SB ostium
area(mm2) Jailing pattern
Patient 1-SB 1 OM-LCx 4.81 Proximal and distal
Patient 2-SB 1 LAD-septal 6.22 Crossing
Patient 2-SB 2 LAD-diagonal 1.14 Distal
Patient 2-SB 3 LAD-septal 1.89 Proximal
Patient 3-SB 1 LAD-diagonal 1.58 Distal
Patient 3-SB 2 LAD-septal 1.42 N/A
Patient 4-SB 1 LCx-OM 1.11 Proximal and distal
Patient 5-SB 1 LAD-septal 1.93 Crossing
Patient 5-SB 2 LAD-diagonal 0.46 Distal
Patient 6-SB 1 LCx-OM 1.37 Crossing
Patient 6-SB 2 OM-LCx 2.23 Distal
Patient 8-SB 1 LCx-OM N/Ay Proximal
Patient 8-SB 2 LCx–posterolateral 0.3 Proximal
Patient 8-SB 3 LCx-OM 0.78 Proximal
SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comgroup: 1.720.82 vs. 1.56 (p¼0.05) and 31.8221.82 vs. 35.6716.96 (p< 0.01),
respectively. At 4-months rates of TLF (2.1% vs 4.0%; p¼0.44), TVF (2.1% vs 4.0%;
p¼0.44) and stent thrombosis (0.0% vs 1.0%; p¼0.33) were low and similar in
Ultimaster and Xience arms respectively. The 9-month primary outcome details will
be provided at presentation.
Conclusions: The short term clinical outcomes in bifurcations with the new Ulti-
master DES shows potential. The planned 5-year follow-up of patients will allow more
clear assessment.
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Background: Optimal treatment of coronary bifurcations with lesions involving a
major side branch (>2.75mm) is unsettled. The randomized Nordic Baltic bifurcation
study IV was ﬁrst to show favorable mid-term results for two-stent techniques
compared to provisional side branch stenting. Two-stent techniques have been asso-
ciated with more stent strut malapposition compared to main vessel only stenting.
Here we present the Nordic Baltic IV OCT substudy.
Methods: Patients included in the Nordic Bifurcation Study IV were offered partic-
ipation in the OCT substudy before randomization. The study stent was Cypher
(Cordis, US) in ﬁrst half of the main study and then Xience (Abbott Vascular, US).
Patients underwent OCT scan post-PCI and at 8 months follow-up. Analysis involved
stent strut malapposition (primary endpoint), strut coverage and ostial side branch
minimal luminal area (MLA) at 8 months follow-up.
Results: A total of 31 patients were included and 27 patients had matched main vessel
follow-up OCT acceptable for analysis. Cypher stent was used in 43 % vs. 31 %
(p¼0.52) in the one-stent vs. two-stent group. Malapposition in the proximal main
vessel after 8 months was 0.12 % vs. 1.10 % (p¼0.10), in the bifurcation segment
towards the side branch 0 % vs. 0.57 % (p¼0.30) and opposite to the side branch; 1.58
% vs. 2.40 % (p¼0.72) for one- and two-stent techniques, respectively. Ostial side
branch MLA was measured using QAngioOCT Cut-plane analysis (Medis Specials,
NL). MLA at baseline was 2.61.2 mm2 in the one-stent group, vs. 4.61.5 mm2
(p¼0.002) in the two-stent group and at 8-month follow-up; 3.33.0mm2 vs. 3.81.5
mm2 (p¼0.64) in the one-stent, vs. two-stent group.
Conclusions: In a randomized comparison of one- and two-stent techniques for
treatment of bifurcation lesions with a large side branch, no signiﬁcant differences in
malapposition were detected. The increased ostial side branch MLA at baseline for
two-stent techniques was not signiﬁcantly different from one-stent techniques at 8-
month follow-up. The OCT ﬁndings support the beneﬁcial mid-term results of two-
stent techniques in bifurcation lesions involving a major side branch.
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Background: Provisional T-stenting (PTS) with regular DES is recommended strat-
egy for coronary bifurcation treatment, however results are not optimal. POLBOS II
study is continuation of POLBOS I study, in which paclitaxel-eluting stent BiOSS
Expert (Balton, Poland) was assessed.
Methods: In POLBOS II study patients with stable CAD or NSTE-ACS were ran-
domized to group where dedicated bifurcation sirolimus-eluting BiOSS LIM stent
was implanted or to group where regular DES was used. The enrollment lasted be-
tween November 2012 and December 2013 in ﬁve centers in Poland and Spain. PTS
was default strategy. An angiographic control was planned at 12 months in all pa-
tients. The primary end-point is MACE after 12 months. Here, we present complete 6-
month clinical follow-up. At the time of TCT 2014 angiographic follow-up will be
almost completed.
Results: There were implanted 104 BiOSS LIM stents and 100 regular DES. Mean
age did not differ signiﬁcantly between groups (BiOSS vs DES: 66.7 vs 65.5 yrs). In
BiOSS group there were signiﬁcantly more patients with hypertension (97.2% vs
87.5%), diabetes (44.4% vs 37.5%) and chronic kidney disease (13.9% vs 9.5%). TheB54 JACC Vol 64/11/Suppl B j Sedominant vessel was LAD (BiOSS vs DES: 46% vs 57%) followed by LMS (37%
vs 18%). According to Medina classiﬁcation true bifurcations were present in 65%.
In DES group 20% of stents eluted sirolimus, 24% - paclitaxel and 45% - ever-
olimus. There were following nominal stent parameters: in BiOSS group
3.730.43 mm (proximal diameter) x 3.030.4 mm (distal diameter) x 17.72.9
mm (length) and in DES group: 3.290.52 mm x 20.16.9 mm. Except for 1 (1%)
case in DES group and 1 (0.9%) in BiOSS group all stents were implanted suc-
cessfully without any serious periprocedural complications. Regular DES in side
branch was implanted in BiOSS group and DES group, in 5.7% and 2% of cases,
respectively. At six months in BiOSS group there were 2 TLR and in DES group -
1 TLR and 1 TVR.
Conclusions: Collected data demonstrate comparable immediate and short-term
clinical results for both groups. Full data enable to answer the question if BiOSS LIM
is comparable to regular DES and if it is superior to BiOSS Expert stent assessed in
POLBOS I study.
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Background: The observation of tissue bridge growth after bioresorbable scaffold
(BVS) implantation, together with the high strut thickness raises questions about the
long-term patency of side-branches jailed by BVS. We investigated by optical
coherence tomography (OCT), the fate of side-branches jailed by elective BVS im-
plantation at a 5-years follow-up.
Methods: 8/14 living patients enrolled in the Thoraxcenter cohort of ABSORB A,
underwent additional OCT follow-up 5 years post BVS implantation. Side-branches
jailed by BVS were identiﬁed. For assessing side-branch jailing over time, three-
dimensional images of side-branch ostia were obtained by dedicated rendering
software. No struts were identiﬁable in OCT pullbacks, but neointimal bridges had
developed in their place. Neointimal bridges were classiﬁed based on their relative
location to the ostium as proximal, distal, proximal and distal, or crossing. Mean and
minimal thickness was measured in matched frames at 2- and 5-year follow-up using
QCU-CMS. Side-branch ostium area assessment was performed using dedicated
software. Following three-dimensional reconstruction, a cut-plane perpendicular to
the side-branch centerline was selected and side-branch ostium planimetry was
performed.
Results: All side branches were patent with TIMI III ﬂow. Overall, 14 side-branches
were associated with incompletely apposed struts at previous examinations. Neo-
intimal bridges at 5 years were identiﬁed in 13 side-branches, whereas in one no
bridge was visible (Table). Minimal and mean thickness of neointimal bridges over-
lying side-branches were respectively reduced from 24192mm and 341106mm at 2
years to 161107mm and 227119 at 5 years (p< 0.01)Conclusions: At long-term after BVS implantation, jailed side-branch ostia are
preserved, while side-branch related struts have been replaced by thin tissue
bridges.ptember 13–17, 2014 j TCT Abstracts/Coronary Lesions - Bifurcations
